Find Academic Supervisors

Britt Adamson is an Associate Professor in the Department of Molecular Biology and the Lewis-Sigler Institute for Integrative Genomics at Princeton University, where she serves as Director of the Undergraduate Program in Quantitative and Computational Biology. Her lab investigates molecular networks in human cells with focus on stress response mechanisms and genome editing technologies. She received her B.S. in Biology from the Massachusetts Institute of Technology (2005) and Ph.D. in Genetics and Genomics from Harvard University (2012), followed by postdoctoral training at UCSF under Jonathan Weissman supported by a Damon Runyon Cancer Research Foundation Fellowship. Adamson's research centers on how cells organize stress response networks during DNA damage and endoplasmic reticulum stress, developing CRISPR-based functional genomics and single-cell sequencing tools to map molecular behaviors. Her work bridges fundamental cell biology with therapeutic applications in genome editing. Analysis of her 15 most recent publications reveals dominant themes in precision genome editing (prime/base editing optimization) and systematic dissection of DNA repair pathways through combinatorial CRISPR screening. Her lab consistently integrates computational approaches with high-resolution experimental techniques to uncover context-dependent cellular behaviors. Her scientific recognitions include: Damon Runyon Cancer Research Foundation Postdoctoral Fellowship Princeton IP Accelerator Award (2025) STAT Who to Know: 10 Scientists leading a new generation of gene editors (2024) Adamson actively mentors eight graduate students (including alumni Ann Cirincione and Jun Hussmann) and two postdocs, with research funded through institutional awards and collaborative grants. Her lab's technological developments have enabled projects spanning virology, immunology, and developmental biology. The Adamson Lab operates within Princeton's Lewis-Sigler Institute for Integrative Genomics, fostering an interdisciplinary environment that merges cell biology, genomics, and computational science. Current projects focus on improving prime editing efficiency and understanding stress response adaptation in disease contexts.

• Stress Response Networks
• DNA Damage Response
• Genome Editing
• +3 more

Matthew Lakin is an Associate Professor with tenure in the Department of Computer Science at the University of New Mexico, with a courtesy appointment in the Department of Chemical & Biological Engineering. He is affiliated with the UNM Center for Biomedical Engineering and the School of Engineering, and collaborates extensively with the UNM Health Sciences Center and external institutions. Education: Ph.D., Computer Science, University of Cambridge, 2010 M.A. (Cantab), University of Cambridge, 2009 B.A. (Hons), Computer Science, University of Cambridge, 2005 Dr. Lakin's research focuses on molecular computing, DNA nanotechnology, synthetic biology, and formal verification of biomolecular circuits. He develops computational models and experimental systems for programmable biological devices, especially using heterochiral DNA to enhance stability in living cells. His work spans software tools for biodesign and experimental validation in mammalian systems, with applications in nanomedicine and biosensing. The recent publications highlight a strong trend in engineering robust, intelligent biomolecular systems. His work integrates machine learning concepts into chemical reaction networks, advances geometric modeling of DNA systems, and pioneers L-DNA-based circuits for intracellular applications. The research spans theoretical foundations, software tools, and wet-lab experimentation, emphasizing interdisciplinary innovation. Scientific Awards: Presidential Early Career Award for Scientists and Engineers (PECASE), 2025 NSF CAREER Award, 2021 UNM School of Engineering Junior Faculty Research Excellence Award, 2021 Multiple student awards under his mentorship, including the Outstanding Graduate Student Award and DNA28 Best Student Presentation recognition Dr. Lakin has advised numerous graduate and undergraduate students, including Ph.D. graduates in Biomedical Engineering and Computer Science. He leads major funded projects such as the NSF CAREER grant on heterochiral molecular computing, an EPSCoR Research Fellowship, and a $3M NSF grant on heavy metal biosensing in collaboration with Native American communities. He is also PI on multiple NSF grants related to synthetic cells and nucleic acid technologies. He directs the Lakin Lab for Programmable Biology, which operates within the Department of Computer Science and collaborates with Chemical & Biological Engineering and the Center for Biomedical Engineering. The lab emphasizes both computational modeling and experimental molecular biology, and runs an NSF-funded biotechnology summer camp in partnership with ¡Explora! science museum to strengthen STEM education in New Mexico.

• Molecular Computing
• DNA Nanotechnology
• Synthetic Biology
• +7 more

Professor Richard Wade-Martins is a leading academic in University of Oxford 's Department of Physiology, Anatomy and Genetics . He directs the Molecular Neurodegeneration Research Laboratory and the Oxford Parkinson’s Disease Centre (OPDC). With degrees from Cambridge (MA) and Oxford (DPhil), he has held prestigious fellowships including Wellcome Trust Research Career Development Fellowship and NIH reviewer roles. His research targets molecular mechanisms in Parkinson’s and Alzheimer’s diseases through iPSC models , transgenic mice , and lysosomal function studies . He pioneered work on SNCA , MAPT , and LRRK2 gene pathways. Current projects focus on gene therapy and mitochondrial dysfunction in neurodegeneration. Key publications (2019–2025) reveal trends in single-cell transcriptomics , calcium channel inhibition , and TFEB/TFE3 lysosome modulation . His awards include Wellcome Trust Fellowships and advisory roles for Parkinson's UK , Alzheimer's Research UK , and EU consortia like StemBANCC and EFACTS . He leads the UK Dementia Platform iPSC Initiative and serves on international boards in Luxembourg and Canada.

• Neurodegenerative Diseases
• Molecular Neuroscience
• Stem Cell Research
• +3 more

Prof. Dr. Ralph Bock serves as Director of Department 3: Organelle Biology, Biotechnology and Molecular Ecophysiology at the Max Planck Institute of Molecular Plant Physiology in Potsdam, Germany, where he also leads the Organelle Biology and Biotechnology research group. Previously, he held positions as C4 Professor for Plant Biochemistry and Biotechnology at the University of Münster (2001-2004) and Group Leader at the Institute of Biology III, University of Freiburg (1996-2001). His academic credentials include: Habilitation: University of Freiburg, 1999 Doctorate: University of Freiburg, 1996 Diploma: University of Halle, 1993 Prof. Bock's research focuses on plant molecular biology with particular emphasis on chloroplast biology, organelle biotechnology, and molecular ecophysiology. His work spans genetic engineering of plastids, photosynthesis research, plant biotechnology applications, and understanding organelle-nucleus communication. He has made significant contributions to developing chloroplast transformation systems and applying them to molecular farming, metabolic engineering, and understanding fundamental processes in plant cell biology. His research has important implications for sustainable agriculture, bioenergy, and pharmaceutical production, particularly through the development of plant-based systems for producing vaccines and therapeutic proteins. Analysis of Prof. Bock's recent publications (2023-2025) reveals a strong focus on chloroplast biology, genetic engineering, and molecular farming applications. His work spans fundamental research on organelle genetics, photosynthesis, and stress responses, as well as applied research on using plant and algal systems for biopharmaceutical production. A notable trend is the increasing use of advanced genetic engineering techniques, including CRISPR-based approaches, to manipulate organelle genomes. His research also shows growing interest in algal systems as alternative expression platforms for molecular farming, particularly red algae like Porphyridium for producing viral antigens and glycoproteins.

• Plant Molecular Biology
• Chloroplast Biology
• Organelle Biotechnology
• +7 more

Xuguo (Joe) Zhou is a Professor of Entomology at the University of Illinois at Urbana-Champaign, holding the Kearns, Metcalf and Flint Endowed Chair. He is affiliated with the Carl R. Woese Institute for Genomic Biology and the College of Liberal Arts & Sciences. His research focuses on Behavior, physiology, and genomics of social insects Chemical communication in insect systems Insect-plant interactions Recent publications highlight his work in RNA interference mechanisms in beetles, CRISPR gene editing applications in insect pigmentation, and studies on herbicide degradation pathways. These contributions span molecular entomology, agricultural biotechnology, and environmental microbiology. Zhou's work integrates genomic approaches with ecological and physiological studies, particularly evident in his studies on gene function analysis in pest species and development of RNA-based biopesticide strategies. He is based in Morrill Hall, Urbana, Illinois, and can be contacted at xgzhou@illinois.edu.

• Entomology
• Behavioral Ecology
• Physiology
• +3 more

Zhiming Cai is a Visiting Professor at the National Cancer Institute (NCI) and holds multiple leadership roles in China, including President of Shenzhen Medical Association, Deputy Director of Carlson International Oncology Center at Shenzhen University, and Director of the Guangdong Key Laboratory of Systemic Biology and Synthetic Biology in Genitourinary Oncology. As an Outstanding Principal Investigator at the Chinese Academy of Science's Institute of Synthetic Biology, he leads groundbreaking research in cancer genomics and synthetic biology. Doctor Philosophiae Honoris Causa, The National Academy of Science of Ukraine Fellow, American Institute for Medical and Biological Engineering (AIMBE) His research focuses on synthetic biology applications for cancer therapy , including engineered cell treatments and artificial gene circuits for tumor targeting. Notable work includes the "Remodeling Tumor Suppressor Theory" and CRISPR-based signal transduction systems that earned recognition from Nobel laureates and top-tier journals. With over 330 publications and an H-Index of 36, Cai's work has appeared in Nature , Cell , and European Urology . His research team has successfully treated over 200 advanced tumor patients using synthetic biology approaches, demonstrating clinical translation of cutting-edge technology. Guangdong Medical Natural Science Award (First Class) May 1st Labor Medal (China's highest worker award) State Council Special Allowance Expert National Model Worker International Genetically Engineering Machine Competition Gold Award Cai directs multiple high-profile research institutions including the National Tumor Genome Application Engineering Laboratory and the Academic Committee of the National and Local Joint Medical Synthetic Biology Engineering Laboratory. His work bridges basic research with clinical applications in genitourinary oncology through systematic biology approaches.

• Synthetic Biology
• Genitourinary Oncology
• Genomics
• +4 more

Ueli Grossniklaus is an Ordinary Professor at the University of Zurich within the Faculty of Mathematical and Natural Sciences , affiliated with the Department of Plant and Microbiology . His work focuses on plant developmental biology, particularly epigenetic and genetic mechanisms governing reproduction and adaptation. Key Courses: Epigenetics, Plant Biology Workshop, Group Seminars on Current Research Laboratory Techniques: Advanced methods in plant cell mechanics, transcriptomics, and genome editing Research Interests span plant epigenetics, reproductive biology, and the interplay between environmental stress and genetic regulation. He investigates: Mechanistic control of gametogenesis and fertilization Epigenetic contributions to plant adaptation Evolutionary implications of asexual reproduction Biophysical forces in plant cell growth Publication Trends (2025–2018) reveal expertise in: Arabidopsis and fern model systems Epigenetic regulation (DNA methylation, histone dynamics) Apomixis and hybrid seed failure mechanisms Biomechanics of pollen tubes and carnivorous plants Genome editing tools (CRISPR) and long-read sequencing Scientific Collaborations include interdisciplinary projects on: Microfluidic devices for plant cell analysis Gene drive ecology and ethics 3D imaging of plant reproductive structures Advising and Grants focus on mentoring through research internships in developmental biology, genetics, and systems biology. His lab engages in: Epigenetic response to environmental stress Cell wall mechanics in reproduction Computational modeling of plant growth Laboratory Teams integrate plant biologists, bioengineers, and computational scientists to study: Mechanistic gene regulation Evolutionary developmental biology Microrobotics for cellular force measurement

• Plant Developmental Biology
• Epigenetics
• Plant Genetics
• +5 more

Michael Boutros is a Full Professor at Heidelberg University and Head of Division at the German Cancer Research Center (DKFZ). He currently serves as Dean of the Medical Faculty at Heidelberg University (since 2023) and Director of the Marsilius Kolleg (since 2020). He has held leadership roles including Coordinator of the Functional and Structural Genomics Program at DKFZ (2014–2023) and Acting Scientific Director (2015–2016). His academic base is within the Medical Faculty, focusing on molecular oncology and functional genomics. PhD, Witten/Herdecke University (1993–1996) Postdoctoral Research, Harvard Medical School (1999–2003) MPA, John F. Kennedy School of Government, Harvard University (1999–2001) Additional training: Cold Spring Harbor Laboratory, SUNY Stony Brook His research centers on Wnt signaling, functional genomics, and cancer pathways. He leads major research initiatives such as CRC 1324 on Wnt signaling and the ERC Synergy Grant DECODE. His work integrates high-throughput screening, CRISPR, and systems biology to dissect signaling networks in cancer and development. He has pioneered genome-wide RNAi and CRISPR screens to identify novel regulators of Wnt signaling across models. The 15 most recent articles reflect a strong focus on Wnt pathway regulation using functional genomics in both Drosophila and mammalian systems. Themes include high-throughput screening, CRISPR-based validation, cross-species conservation, and therapeutic targeting. Keywords span Cancer Biology, Systems Biology, and Signal Transduction, with subfields like RNAi, ubiquitination, stem cell regulation, and machine learning in image analysis. Michael Boutros has received numerous scientific honors: Elected member, Leopoldina National Academy of Sciences (2022) Elected member, Heidelberg Academy of Sciences (2022) EMBO Member (2013) ERC Advanced Grant (2012) Johann-Georg Zimmermann Research Award (2007) EMBO Young Investigator (2005) Member, 'Die Junge Akademie' (2003) He has been a recipient of the Emmy-Noether Program, McCloy Fellowship, Boehringer Ingelheim PhD Fellowship, Studienstiftung Fellowship, and Fulbright Fellowship. As a mentor and research leader, he has supervised numerous early-career scientists and coordinated large collaborative grants including the FP7 'CancerPathways' project. He currently serves as Speaker of the Research and Strategy Commission at Heidelberg University and Managing Director of the Health and Life Science Alliance Heidelberg Mannheim. He leads the CRC 1324 on Wnt signaling and is Coordinating PI of the ERC Synergy Grant DECODE. He is also Spokesperson of DFG Research Group 1036 and Coordinator of the former FP7 Coordinated Project 'CancerPathways'. His lab employs cutting-edge functional genomics tools to decode signaling networks in cancer and development.

• Functional Genomics
• Structural Genomics
• Wnt Signaling
• +7 more

Dr. Lida Derevnina is a leading researcher in plant-pathogen interactions and immune receptor networks at the University of Cambridge , affiliated with the School of Biological Sciences and the Department of Plant Sciences . She heads the Crop Pathogen Immunity Group at the Crop Science Centre , focusing on NLR (Nucleotide-binding and Leucine-Rich Repeat) immune receptor networks and pathogen effector functions to engineer durable crop resistance. Education: PhD in Plant Pathology and Phytopathology, University of Sydney (2008-2012) BSc in Agricultural Science, University of Sydney (2004-2007) Her research explores how pathogens evade plant immunity through effector proteins and how NLR networks can be bioengineered to counteract these mechanisms. This work bridges molecular biology, evolutionary genetics, and sustainable agriculture, with recent advances in resistosome activation models and effectorome characterization. Scientific awards include the Crop Science Centre Fellowship (2022) , Marie Skłodowska-Curie Individual Fellowship (2016) , and the Jeanie Borlaug Laube Women in Triticum Award (2012) . Her work has been published in top journals such as Science , Nature , and PLoS Biology . Dr. Derevnina is actively engaged in public outreach, including the Talking Biotech podcast and a YouTube video explaining plant immunity . Her laboratory collaborates on projects related to global food security and pathogen genomics.

• Plant Pathology
• Plant Immunity
• Molecular Plant Pathology
• +3 more

Pavel P. Kuksa is a Research Assistant Professor in the Department of Pathology and Laboratory Medicine, specializing in bioinformatics, computer science, and functional genomics. His work focuses on high-throughput sequencing analysis, chromatin interaction data, and developing scalable software platforms for genomics research.

• Bioinformatics
• Computer Science
• Functional Genomics
• +5 more

Cameron A. Myhrvold is an Assistant Professor of Molecular Biology at Princeton University, leading the Myhrvold Lab. His research focuses on CRISPR-based technologies to study viral and host RNA, with applications in detecting and combating RNA viruses like SARS-CoV-2. He specializes in developing Cas13-based tools for multiplexed nucleic acid detection, host-pathogen interaction analysis, and RNA perturbation. Education: A.B. in Molecular Biology from Princeton University (undergraduate), Ph.D. in Systems Biology from Harvard University. His postdoctoral work at Harvard involved pioneering CRISPR-Cas13 technologies, leading to innovations like CARMEN, CARVER, and SHINE. Research interests include: CRISPR-based RNA editing, quantitative nucleic acid detection, systems biology of viral infections, and translating technologies for global health. His lab emphasizes deploying diagnostics in resource-limited settings and studying viral dynamics across diverse tissues and infection conditions. Notable achievements: Named NEBEC Emerging Young Investigator. His work has advanced field-deployable viral diagnostics and multiplexed RNA analysis tools. Collaborates with institutions like the Broad Institute and the CDC on pandemic response initiatives. Current projects include developing quantitative CARMEN variants for gene expression analysis, high-throughput screening of Cas13-virus interactions, and applying CRISPR tools to study influenza and SARS-CoV-2 in animal models.

• CRISPR-based technologies
• Viral RNA studies
• Host-pathogen interactions
• +7 more

Lars Aagaard is an Associate Professor at the Department of Biomedicine - Research and Education, Aarhus University, Denmark. He is based at the Bartholin Building in Aarhus C and is actively engaged in research and teaching in the fields of gene therapy, RNA interference, and genome editing. His work focuses on developing viral vectors, particularly AAV and lentiviral vectors, for ocular gene therapy targeting retinal diseases such as age-related macular degeneration and diabetic retinopathy. His research interests include the development of Dicer-independent RNAi systems, combinatorial gene therapy using microRNA and CRISPR/Cas9, and the delivery of RNA- and protein-based therapeutics. He also teaches Genetics and Personalized Medicine and supervises postdoctoral researchers, PhD, master's, and undergraduate students. The recent publications (2022–2024) reflect a strong trend in RNAi therapeutics, viral vector engineering, and translational applications in ocular and systemic diseases. Themes include gene silencing, immune modulation, and regenerative approaches using engineered cells. Aagaard actively contributes to the scientific community as a reviewer for journals such as Nature and Molecular Therapy . He has participated in key international conferences including ARVO, ASGCT, and ESGCT, demonstrating ongoing engagement with the global gene therapy community. Supervision of postdocs, PhD, master’s, and undergraduate students Active participation in international conferences and workshops Collaborative research across institutions, including Universidade Federal de Sao Paulo He is involved in both basic and translational research, with potential for clinical applications in gene and cell therapy.

• Gene therapy
• RNA interference
• Viral vectors
• +11 more

Lukas Edward Dow is a Professor of Biochemistry and Biophysics at Weill Cornell Medical College (2025-present) and holds a secondary appointment in Medicine. His research spans genetic and non-genetic resistance mechanisms in KRAS-driven cancers, WNT signaling, and CRISPR-based cancer modeling. Ph.D. and B.Sc. from University of Melbourne Focus on CRC, pancreatic, breast, and prostate cancers Research interests include genetic resistance mechanisms , CRISPR applications , WNT pathway dependencies , and tumor microenvironment dynamics . Key publications reveal trends in mutant-specific therapies , epithelial plasticity , and precision genome editing . Current research projects funded by National Cancer Institute and Department of Defense investigate KRAS allelic imbalance, R-Spondin sensitization, and WNT pathway alterations. External collaborations include scientific advisory roles at Mirimus, Inc. and consulting at Revolution Medicines, Inc. His lab develops genetically engineered mouse models and organoid systems for studying cancer progression, with emphasis on metastasis , drug resistance , and epigenetic adaptations . The work has significant implications for improving cancer therapies through context-dependent targeting .

• Cancer Biology
• Genetics
• Molecular Biology
• +5 more

Professor Johanita Kruger is a faculty member at the University of Applied Sciences Fulda, Germany, where she holds the position of Professor of Food Technology and Nutrition. Previously, she has held roles including Researcher at the University of Hohenheim and Lecturer at the University of Pretoria. Her research focuses on nutrient bioavailability, particularly inhibitors and enhancers of bioactive compounds, with an emphasis on polysorbate micelle absorption mechanisms, food-to-food fortification strategies, and mineral bioavailability in African green leafy vegetables. She collaborates internationally on projects funded by the German Research Foundation (DFG) and USAID, addressing issues such as micronutrient deficiencies and food processing innovations. Her educational background includes a PhD in Nutrition from the University of Pretoria, alongside extensive post-doctoral and research experience across multiple institutions. University of Applied Sciences Fulda, Germany (2023–present) University of Hohenheim, Stuttgart (2020–2023; 2016–2018) University of Pretoria, South Africa (2015–2015; 2011–2013) Her research interests span food biofunctionality, including the development of novel micellar formulations and the evaluation of food processing techniques to enhance nutrient bioavailability. Key projects include defining food-to-food fortification strategies and investigating iron/zinc bioavailability in traditional African diets. She has contributed to interdisciplinary collaborations, such as the USAID Feed the Future Innovation Lab for Food Processing. Publications highlight advancements in polysorbate micelle stability, polyphenol encapsulation, and the efficacy of tropical plant-based fortification. Her work bridges laboratory research and real-world applications, aiming to improve global food security and nutritional outcomes. Laboratory activities include the USAID-funded Food Processing Lab and collaborative projects with institutions in France and Slovenia. No scientific awards are explicitly noted in the provided text. Her advising and grants include DFG funding for micelle absorption studies and contributions to the Kenyan Flour Blending Initiative. Students and lab teams focus on topics like cereal biofortification and nutrient-micelle interactions.

• Food Science
• Nutritional Bioavailability
• Food Fortification Strategies
• +3 more

Scott Bailey, PhD, is a Professor in the Department of Biochemistry and Molecular Biology at Johns Hopkins University, with joint affiliations in the School of Medicine and the Bloomberg School of Public Health. His research focuses on the structural and mechanistic basis of CRISPR-Cas systems and protein-nucleic acid interactions. Education: BSc, University of Sheffield, 1998 PhD, University of Sheffield, 2002 Dr. Bailey’s research centers on understanding how molecular machines recognize and modify nucleic acids, with an emphasis on CRISPR-mediated immunity. Using X-ray crystallography, his lab determines high-resolution structures of CRISPR complexes at various functional stages to derive mechanistic models. These models are tested through mutagenesis and biochemical assays to link structure with function. His work has elucidated mechanisms of Cas9, Type III-B, and Type V systems, contributing significantly to the field of genome editing. Recent publications highlight advancements in Cas9 engineering, genome imaging techniques, and the structural basis of CRISPR targeting. His research has broad implications for biotechnology and therapeutic development. Trends across his articles show a sustained focus on CRISPR mechanisms, structural biology, and nucleic acid biochemistry, with increasing applications in proteomics and imaging. Scientific Awards: Johns Hopkins Presidents Frontier Award - Winner (February 2016) Johns Hopkins Presidents Frontier Award - Finalist (January 2015) Shikani/El Hibri Prize for Discovery and Innovation - JHSPH (February 2015) Ho-Ching Yang Memorial Faculty Award - JHSPH (May 2010) Dr. Bailey advises graduate students and postdoctoral researchers in the Molecular Biophysics and Biochemistry programs. His lab has been supported by competitive grants, including the Johns Hopkins Discovery Awards (2020). He teaches advanced courses in molecular biology and gene editing, contributing to both PhD and Master’s level training. The Bailey Lab is an active research group that integrates structural biology, biochemistry, and molecular genetics to dissect CRISPR mechanisms. The team includes PhD students, postdoctoral fellows, and research staff who collaborate on projects spanning structural determination, functional assays, and novel method development.

• CRISPR-Cas
• Structural Biology
• Protein-Nucleic Acid Interaction
• +5 more